| http://www.w3.org/ns/prov#value | - Further information regarding these and other risks...Watson Announces Limited Recall Of Fentanyl Transdermal System... manufacturing; the difficulty of predicting the timing or outcome of FDA or other regulatory agency approvals or actions, if any; and other risks and uncertainties detailed in Watson's periodic public filings with the Securities and Exchange Commission, including but not limited
|
